Leaflet MISYO 10mg / ml concentrate for oral solution

Product code:
W60166004
Quantity:
1
Indicated for:
severe pain; opioid dependence
Route of administration:
oral
Substance:
methadone (opioid analgesic)
ATC
N07BC02 — Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence

Precautions:

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol

Avoid alcohol during treatment.

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning

Older people may have an increased risk of side effects.

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Methadone is a synthetic opioid analgesic primarily used for the treatment of severe chronic pain and as part of substitution therapy for opioid dependence, such as heroin addiction. It is a long-acting medication that helps reduce withdrawal symptoms and cravings for opioids.

In pain management, methadone is effective for severe pain that does not respond to other analgesics. It is also used in substitution programs to stabilize opioid-dependent patients, reducing the risk of relapse and the use of illicit drugs. Methadone does not produce the intense euphoria associated with other opioids, making it more suitable for this purpose.

However, methadone use requires careful monitoring, as it can cause side effects such as respiratory depression, excessive sedation, or cardiac arrhythmias. It is essential for patients to adhere to the prescribed dosage and be supervised by a physician, especially during the initial weeks of treatment.

Methadone is a critical medication in managing opioid dependence and chronic pain, but its use should be part of a comprehensive treatment plan that includes counseling and psychological support. Patients should be informed about the risks and benefits of the treatment to ensure safe and effective use.

General data about MISYO 10mg / ml

Substance:
methadone
Date of latest medicines list:
01-06-2026
Product code:
W60166004
Concentration:
10mg / ml
Pharmaceutical form:
concentrate for oral solution
Quantity:
1
Product type:
Generic medicine
Price:
435.74 RON
Prescription status:
TAB2 — Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.

Marketing authorisation

Manufacturer:
ALKALOID-INT D.O.O. - SLOVENIA
Holder:
INN-FARM D.O.O. - SLOVENIA
Number:
10898/2018/04
Shelf life:
2 years-after packing for marketing;after the first opening of the bottle-90 days;dupa diluare-14 days

Pharmaceutical forms available for methadone

Concentrations available for methadone

  • 10mg
  • 10mg/ml
  • 2.5mg
  • 20mg
  • 40mg
  • 5mg
  • 5mg/ml

Compensation lists for MISYO 10mg / ml Inn-Farm

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price
435.74 RON
Copayment
435.74 RON
Patient
0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price
435.74 RON
Copayment
435.74 RON
Patient
0.00 RON

NHP 11.1 (C2) - Treatment of drug addiction

Price
435.74 RON
Copayment
435.74 RON
Patient
0.00 RON